Elijah Stevens
Psychiatric/Mental Health · Binghamton, NYNPI 1326131954
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $102,450 of the $131,259 with a category attached, or 78.1%. 12 manufacturers reported payments, led by AbbVie at 46.3% of the total. Reporting peaked in 2021 at $42,862 and has fallen 76.1% since, to $10,254 in 2025. Among psychiatric/mental health clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 424 payments — averaging $309.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$61K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$51K
- Alkermes, Inc.$17K
- Teva Pharmaceuticals USA, Inc.$929
- Otsuka America Pharmaceutical, Inc.$539
- Johnson & Johnson$457
- plus $502 from 6 others
What the payments were for
- Consulting fees$7,7256%
- Speaking & faculty fees$102,45078%
- Travel & lodging$11,8609%
- Food & beverage$9,1777%
- Education$470%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 165 | $60,763 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 136 | $51,191 |
| Alkermes, Inc. | 56 | $16,878 |
| Teva Pharmaceuticals USA, Inc. | 22 | $929 |
| Otsuka America Pharmaceutical, Inc. | 18 | $539 |
| Johnson & Johnson | 9 | $457 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $212 |
| Axsome Therapeutics, Inc. | 3 | $165 |
| E.r. Squibb & Sons, L.L.C. | 2 | $39 |
| Lundbeck LLC | 2 | $36 |
| Neurocrine Biosciences, Inc. | 2 | $32 |
| Indivior Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$63,444
- VRAYLAR$58,544
- CAPLYTA$49,147
- ARISTADA INITIO$15,861
- LYBALVI$405
- UZEDY$236
- REXULTI$213
- Austedo XR$207
- SPRAVATO$165
How this compares
$131,259 in reported general payments places this provider in the 95th percentile of 2,385 psychiatric/mental health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CaplytaLumateperone Tosylate | 51 | $83,493 |
| Abilify MaintenaAripiprazole | 14 | $39,983 |
| VivitrolNaltrexone Microspheres | 13 | $22,077 |
| Lamotrigine ErLamotrigine | 15 | $1,258 |
| Aripiprazole | 13 | $547 |
| Olanzapine | 19 | $370 |
| Duloxetine Hcl | 24 | $216 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 14 | $197 |
| Prazosin Hcl | 15 | $147 |
| Hydroxyzine Hcl | 16 | $129 |
| Quetiapine Fumarate | 26 | $108 |
| Clonidine Hcl | 11 | $77 |
| Trazodone Hcl | 24 | $50 |
| Alprazolam | 20 | $30 |
| Clonazepam | 13 | $15 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $51,191 | $83,49351 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $539 | $39,98314 claims |
| Alkermes, Inc.Vivitrol | $16,878 | $22,07713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,385 psychiatric/mental health providers in New York.
Other psychiatric/mental health in Binghamton
- Tammy RussoNiskayuna$568K
- Carrie EdickSchenectady$484K
- Eric SpronzCentereach$448K
- Terry Jo Brooks-DevlinTonawanda$176K
- Kevin SiewersStaten Island$155K
- Daniel BreeyearNiskayuna$149K
- Kayanna JonasFar Rockaway$93K
- Alexis CrisafiFishkill$70K
- Vera ImperialeAlbany$69K
- Matthew SharpePenfield$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.